The Globe and Mail reports in its Friday, June 26, edition that Toronto-based Jamieson Wellness is in discussions with potential buyers about a sale that could exceed $2-billion. The Globe's Jameson Berkow writes that Jamieson received an unsolicited takeover offer from an unnamed firm and is engaging with other interested parties. Bank of Montreal and Canaccord Genuity have been hired to provide financial advice on the process. "There can be no assurance that this process will result in any transaction," the company said. Jamieson made the announcement after Bloomberg News reported that the company was in talks. "A potential sale of the company has been a key investor debate," Royal Bank of Canada analyst Ryland Conrad, who has a buy rating on Jamieson and a price target of $46 a share, said on Wednesday. "Given the company's recent execution and valuation levels, we are not overly surprised by the news." Potential acquirers likely include both private equity investors and Jamieson's rivals in the vitamin, mineral and supplement, or VMS, industry, Mr. Conrad said. Some of the largest players in the global VMS sector include Nestle, Centrum maker Haleon and Herbalife in the United States.